Abstract:"Science means constantly walking a tight rope" Heinrich Rohrer, physicist, 1933. Community-acquired pneumonia (CAP) is the leading cause of death from infectious disease worldwide and disproportionately affects older adults and children. In high-income countries, pneumonia is one of the most common reasons for hospitalisation and (when recurrent) is associated with a risk of developing chronic pulmonary conditions in adulthood. Pneumococcal pneumonia is particularly prevalent in older adults, and here, pneumonia is still associated with significant mortality despite the widespread use of pneumococcal vaccination in middleand high-income countries and a low prevalence of resistant organisms. In older adults, 11% of pneumonia survivors are readmitted within months of discharge, often with a further pneumonia episode and with worse outcomes. In children, recurrent pneumonia occurs in approximately 10% of survivors and therefore is a significant cause of healthcare use. Current antibiotic trials focus on short-term outcomes and increasingly shorter courses of antibiotic therapy. However, the high requirement for further treatment for recurrent pneumonia questions the effectiveness of current strategies, and there is increasing global concern about our reliance on antibiotics to treat infections. Novel therapeutic targets and approaches are needed to improve outcomes. Neutrophils are the most abundant immune cell and among the first responders to infection. Appropriate neutrophil responses are crucial to host defence, as evidenced by the poor outcomes seen in neutropenia. Neutrophils from older adults appear to be dysfunctional, displaying a reduced ability to target infected or inflamed tissue, poor phagocytic responses and a reduced capacity to release neutrophil extracellular traps (NETs); this occurs in health, but responses are further diminished during infection and particularly during sepsis, where a reduced response to granulocyte colony-stimulating factor (G-CSF) inhibits the release of immature neutrophils from the bone marrow. Of note, neutrophil responses are similar in preterm infants. Here, the storage pool is decreased, neutrophils are less able to degranulate, have a reduced migratory capacity and are less able to release NETs. Less is known about neutrophil function from older children, but theoretically, impaired functions might increase susceptibility to infections. Targeting these blunted responses may offer a new paradigm for treating CAP, but modifying neutrophil behaviour is challenging; reducing their numbers or inhibiting their function is associated with poor clinical outcomes from infection. Uncontrolled activation and degranulation can cause significant host tissue damage. Any neutrophil-based intervention must walk the tightrope described by Heinrich Rohrer, facilitating necessary phagocytic functions while preventing bystander host damage, and this is a significant challenge which this review will explore.

Neonatal neutrophils: the good, the bad, and the ugly

Neonatal Sepsis and Neutrophil Insufficiencies

Advantages and Limitations of the Neonatal Immune System

The Role of Microbiota in Neutrophil Regulation and Adaptation in Newborns

Neutrophil CD11b Expression in Healthy Neonates

Neutrophil Function: From Mechanisms to Disease

Immature neutrophils in cord blood exert increased expression of genes associated with antimicrobial function

Neutrophils in community-acquired pneumonia: parallels in dysfunction at the extremes of age

Neonatal neutrophils exhibit reduced NLRP3 inflammasome activation

Neutropenia in Preterm Infants

Neutrophil Extracellular Traps in Adult Diseases and Neonatal Bacterial Infectious Diseases: A Review

Neutrophils in Physiology and Pathology

Neonatal microbiota-epithelial interactions that impact infection

An Impaired Inflammatory Cytokine Response to Gram-Negative LPS in Human Neonates is Associated with the Defective TLR-Mediated Signaling Pathway

Congenital neutropenia and primary immunodeficiency diseases

Innate Immunity of Neonates and Infants

Attenuated innate immune defenses in very premature neonates during the neonatal period

Decreased active oxygen metabolism in neutrophils of preterm infants

Neutrophils in chronic inflammatory diseases

Neonatal sepsis: epidemiology and management

Antibiotics and antifungals in neonatal intensive care units: a review